Does RITUXIMAB-ABBS Cause Progressive multifocal leukoencephalopathy? 8 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Progressive multifocal leukoencephalopathy have been filed in association with RITUXIMAB-ABBS. This represents 0.2% of all adverse event reports for RITUXIMAB-ABBS.
8
Reports of Progressive multifocal leukoencephalopathy with RITUXIMAB-ABBS
0.2%
of all RITUXIMAB-ABBS reports
2
Deaths
1
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From RITUXIMAB-ABBS?
Of the 8 reports, 2 (25.0%) resulted in death, 1 (12.5%) required hospitalization, and 4 (50.0%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB-ABBS. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB-ABBS Cause?
Off label use (2,167)
Intentional product use issue (273)
Dyspnoea (208)
Pain (205)
Rheumatoid arthritis (202)
Intentional dose omission (196)
Fatigue (195)
Drug ineffective (186)
Hypertension (183)
Infusion related reaction (183)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which RITUXIMAB-ABBS Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
RITUXIMAB-ABBS vs RITUXIMAB-ARRX
RITUXIMAB-ABBS vs RITUXIMAB-PVVR
RITUXIMAB-ABBS vs RIVAROXABAN
RITUXIMAB-ABBS vs RIVASTIGMINE
RITUXIMAB-ABBS vs RIVOTRIL